Scientists make major breakthrough in understanding cause of Parkinson’s

Scientists have identified the structure of the PINK1 protein, a breakthrough with potential implications for Parkinson's disease treatment.
PINK1 mutations are linked to Parkinson's, particularly early-onset cases, and the research reveals how these mutations disrupt normal cellular processes in the brain.
The discovery paves the way for developing drugs that could potentially slow or stop Parkinson's progression by targeting PINK1.
The research also looks at how PINK1 binds to mitochondria – the powerhouse of the cell – and stops it from functioning properly.
This breakthrough is hailed as a significant step towards understanding Parkinson's and creating new therapeutic strategies, offering hope for those affected.